For the Inventor, By the Inventor

Enter assignee name

Melbourne, Australia

Peter Maccallum Cancer Institute

USPTO Granted Patents = 18

CIPO Patents = 2

EPO Patents = 9

Forward Citations = 43

Loading Chart...

Loading Chart...

46 inventors (with patents filed for the assignee):

Roger Francis Martin (5 out of 7 patents)

Jonathan White (4 out of 4 patents)

Pavel Nikolaevich Lobachevsky (3 out of 3 patents)

4. Paul J Simmons (3 out of 10 patents)

5. Belinda Sheree Parker (2 out of 2 patents)

6. David Winkler (2 out of 2 patents)

7. Colin Skene (2 out of 2 patents)

8. Sebastian Mario Marcuccio (2 out of 17 patents)

9. William Alexander Denny (1 out of 73 patents)

10. Edouard Collins Nice (1 out of 8 patents)

11. Christian Miller (1 out of 3 patents)

12. Julie Ann Spicer (1 out of 9 patents)

13. Patrick David O'Connor (1 out of 1 patent)

14. Kristiina Huttunen (1 out of 1 patent)

15. Joseph A Trapani (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 12202855 - Modified T cells and uses thereof (2025-01-21),

2. 11866504 - Bispecific polypeptides for engagement of CAR expressing immune cells with antigen presenting cells and uses thereof (2024-01-09),

3. 11828759 - Method of diagnosis (2023-11-28),

4. 11243205 - Method of diagnosis of breast cancer (2022-02-08),

5. RE46943 - Radioprotector compounds and methods (2018-07-09),

6. 9896663 - Leukaemia stem cell line, its method of production and uses thereof (2018-02-20),

7. 9896443 - Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof (2018-02-20),

8. 9862776 - Antibodies against human RYK and uses therefor (2018-01-09),

9. 9724329 - Stimulating immune response (2017-08-08),

10. 9718887 - Methods and products for preventing and/or treating metastatic cancer (2017-08-01),

11. 8999993 - Radioprotector compounds and methods (2015-04-07),

12. 8796277 - Radioprotector compounds and related methods (2014-08-05),

13. 8586557 - Therapy of p53 mutant colon adenocarcinoma, breast cancer and lung cancer (2013-11-19),

14. 8097238 - Cell targeting conjugates (2012-01-17),

15. 7718379 - Identifying haematopoietic stem cells based on cell surface markers (2010-05-18),

The Peter MacCallum Cancer Institute is a leading cancer research, treatment, and education center based in Melbourne, Australia. With a mission to provide world-class care to cancer patients, the institute focuses on delivering innovative treatments and personalized care options. As a comprehensive cancer center, Peter MacCallum Cancer Institute conducts cutting-edge research, operates state-of-the-art facilities, and collaborates with international experts to advance the field of oncology. Through a multidisciplinary approach, the institute strives to improve patient experiences and outcomes in their fight against cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

18 Patents

#10 in Melbourne

#196 in Australia

#33,199 in the World

Melbourne, Australia

Peter Maccallum Cancer Institute

Forward Citations = 43

46 inventors:

Roger Francis Martin (5 out of 7 patents)

Jonathan White (4 out of 4 patents)

Pavel Nikolaevich Lobachevsky (3 out of 3 patents)

4. Paul J Simmons (3 out of 10 patents)

5. Belinda Sheree Parker (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…